TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: <1nMAssay Description:Inhibition of human N-myristoyltransferase assessed as reduction in CoASH production by fluorogenic detection based assayMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: <1nMAssay Description:Inhibition of human NMT1 by fluorescence methodMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human N-myristoyltransferase 1 using [3H]myristoyl-CoA and GCGGSKVKPQPPQAK(biotin)-amide as substrate preincubated for 5 mins prior sub...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human NMT1 using [3H]-myristoyl-coA/biotinylated CAP5.5 as substrate after 15 mins by scintillation/luminescence counting methodMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of human NMT1 using [3H]-myristoyl-coA/biotinylated CAP5.5 as substrate after 15 mins by scintillation/luminescence counting methodMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of human N-myristoyltransferase 1 using [3H]myristoyl-CoA and GCGGSKVKPQPPQAK(biotin)-amide as substrate preincubated for 5 mins prior sub...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 7nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 7nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 7nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 8nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of human NMT1 using [3H]-myristoyl-coA/biotinylated CAP5.5 as substrate after 15 mins by scintillation/luminescence counting methodMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines
Curated by ChEMBL
Frontier Medicines
Curated by ChEMBL
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair